Designed for ease of use, LifeSPARC offers versatile, simple, yet powerful advanced circulatory support to help more patients in a variety of hospital settings.
The LifeSPARC controller’s streamlined user interface and the simple-to-prime pump help you manage patients with confidence in varying environments.
With 40% more power than the previous generation and a pump capable of 8 LPM of blood flow surgically and 5 LPM percutaneously, LifeSPARC is designed for a variety of cardiac and respiratory rescue conditions.
With a two-hour battery backup and a small, integrated pump and motor, the LifeSPARC system can be primed in minutes and easily transported in the hospital during use.
The lightweight controller features four simple screens and visual and audio alarms. It can be mounted to an IV pole or removed from the docking station for in-hospital transport.
The system features the world’s only sterile on-patient pump, which reduces circuit surface area to decrease inflammatory response and eliminate the need for a heater/cooler.
The unique sterile priming basin uses gravity for a rapid, repeatable priming process. This plug-and-play design allows the system to be primed within 5 minutes.
H 30.48 cm (12 in)
W 21.59 cm (8.5 in)
D 20.32 cm (8 in)
|WEIGHT||16.5 lbs. (7.48 kg)|
|INTERFACE||Four loop panel GUI|
|ALARMS||Mulitple visual and audio indications|
AC power (docking station)
Removable, rechargeable Lithium ion batteries
5 LPM percutaneous
8 LPM surgical
|Speed||2,000 - 7,500 RPMs|
|Max Pressure||600 mmHg at 7,500 RPM|
|Bearing||Magnetic pivot bearing|
|Pump Body Priming Volume||16 mL|
LifeSPARC Procedure Kits
The four ready-to-deploy kits are designed to take the complexity out of emergent rescue. They are self-contained, turn-key tools for fast multidisciplinary support.
In the U.S., the LifeSPARC® system is intended to pump blood through an extracorporeal circuit for periods lasting less than six hours for the purpose of providing either: (i) full or partial cardiopulmonary bypass (i.e., circuit includes an oxygenator) during open surgical procedures on the heart or great vessels; or (ii) temporary circulatory bypass for diversion of flow around a planned disruption of the circulatory pathway necessary for open surgical procedures on the aorta or vena cava.